DMC Group’s Boston Scientific BSX Stock Holding History

DMC Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$484K	Sell	7,721 -581	-7%	-$46.5K	0.33%	86
2025 Q4	$792K	Buy	8,302 +751	+10%	+$73.6K	0.53%	57
2025 Q3	$737K	Buy	7,551 +33	+0.4%	+$3.42K	0.51%	62
2025 Q2	$808K	Sell	7,518 -318	-4%	-$32.2K	0.63%	49
2025 Q1	$790K	Sell	7,836 -63	-0.8%	-$6.34K	0.64%	49
2024 Q4	$706K	Buy	7,899 +947	+14%	+$83.4K	0.57%	53
2024 Q3	$583K	Buy	6,952 +1,034	+17%	+$81.5K	0.47%	74
2024 Q2	$456K	Buy	5,918 +691	+13%	+$50.6K	0.39%	80
2024 Q1	$358K	Buy	5,227 +312	+6%	+$20.1K	0.31%	93
2023 Q4	$284K	Buy	4,915 +868	+21%	+$46.3K	0.27%	103
2023 Q3	$214K	Buy	+4,047	New	+$212K	0.2%	114

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DMC Group's BSX Position: Q1 2026 in Review

DMC Group reduced its Boston Scientific (BSX) stake by 7% in Q1 2026, selling an estimated $46.5K and leaving 7,721 shares worth $484K. The position accounts for 0.33% of the portfolio, ranked #86.

DMC Group first reported a position in BSX in Q3 2023 and has held it in 11 quarters since. The position peaked at $808K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

DMC Group held 7,721 shares of Boston Scientific worth $484K as of Q1 2026.
DMC Group sold 581 Boston Scientific shares in Q1 2026, an estimated $46.5K.
Boston Scientific made up 0.33% of DMC Group's portfolio in Q1 2026, its #86 holding.
DMC Group first reported a position in Boston Scientific in Q3 2023 and has held it in 11 quarters since.
DMC Group's Boston Scientific position peaked at $808K in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on DMC Group's 13F filing for Q1 2026, filed 30 Apr 2026.